how your Menstrual Cycle can impact GLP-1 Medications and your weight
- AJ Hill Aesthetics

- 3 hours ago
- 3 min read
Weight loss medications like Wegovy and Mounjaro, which belong to the GLP-1 class, have gained attention for their ability to support appetite control and improve metabolic health. Yet, many women notice that their weight loss progress can fluctuate throughout their menstrual cycle. Understanding how the menstrual cycle affects the effectiveness of GLP-1 medications can help women manage these changes and maintain steady progress.
This article explores the interaction between GLP-1 medications and the menstrual cycle, the potential impact on weight loss, and practical tips to offset any challenges.

How GLP-1 Medications Work and Their Role in Weight Loss
GLP-1 medications, including Wegovy and Mounjaro, mimic the glucagon-like peptide-1 hormone that regulates appetite and insulin secretion. They help reduce hunger, slow gastric emptying, and improve blood sugar control. These effects contribute to reduced calorie intake and gradual weight loss.
Women taking these medications often experience significant benefits, but the hormonal fluctuations during the menstrual cycle can influence how the body responds to GLP-1 drugs.
Hormonal Changes During the Menstrual Cycle That Affect Weight Loss
The menstrual cycle is divided into phases: the follicular phase, ovulation, and the luteal phase. Each phase involves different hormone levels, mainly oestrogen and progesterone, which can affect appetite, metabolism, and water retention.
Follicular phase (Day 1 to ovulation): Oestrogen levels rise, often leading to reduced appetite and increased energy expenditure.
Ovulation: Peak oestrogen with a brief surge in luteinising hormone.
Luteal phase (Post-ovulation to menstruation): Progesterone rises, which can increase appetite and cause water retention.
These hormonal shifts can influence how effective GLP-1 medications are at controlling hunger and promoting weight loss.
How the Menstrual Cycle Can Reduce the Effectiveness of GLP-1 Medications
During the luteal phase, increased progesterone may counteract the appetite-suppressing effects of GLP-1 medications. Women might notice:
Increased hunger and cravings, especially for high-calorie or sugary foods.
Reduced satiety, making it harder to stick to calorie goals.
Water retention and bloating, which can mask fat loss on the scales.
Mood changes that affect motivation and adherence to diet and exercise plans.
These factors can lead to a temporary slowdown or plateau in weight loss despite continued use of Wegovy or Mounjaro.
Practical Tips to Manage Menstrual Cycle Effects on GLP-1 Medication
Women can use several strategies to offset the impact of their menstrual cycle on GLP-1 medication effectiveness:
1. Track Your Cycle and Symptoms
Keeping a detailed record of menstrual phases, appetite changes, and medication effects helps identify patterns. Apps or journals can be useful tools.
2. Adjust Nutrition During the Luteal Phase
Focus on high-fibre, protein-rich foods to increase fullness.
Include complex carbohydrates to stabilise blood sugar and reduce cravings.
Stay hydrated to help reduce bloating.
Plan for healthy snacks to manage increased hunger without overindulging.
3. Maintain Consistent Physical Activity
Exercise can help regulate mood, reduce water retention, and support metabolism. Gentle activities like walking or yoga may be preferable during the luteal phase if energy dips.
4. Prioritise Sleep and Stress Management
Poor sleep and stress can worsen hormonal imbalances and appetite control. Techniques such as mindfulness, relaxation exercises, and maintaining a sleep routine support overall wellbeing.
5. Consult Healthcare Providers
Discuss any significant fluctuations in weight loss or side effects with a healthcare professional. They can assess whether medication adjustments or additional support are needed.

Understanding the Bigger Picture: Weight Loss Is Not Linear
Weight loss often follows a non-linear path, especially for women using GLP-1 medications. The menstrual cycle adds another layer of complexity. Temporary stalls or slight weight gains during certain phases do not mean the medication is ineffective.
By recognising these natural fluctuations, women can avoid frustration and stay committed to their goals.
Additional Considerations for Women Using Wegovy or Mounjaro
Medication timing: Some women find taking GLP-1 medications at the same time each day helps maintain consistent effects.
Side effects: Nausea or digestive changes may vary with the cycle and should be monitored.
Individual differences: Every woman’s cycle and response to medication differ, so personalisation is key.
Final Thoughts on Managing Weight Loss with GLP-1 Medications and Menstrual Cycles
Women using GLP-1 medications like Wegovy and Mounjaro should expect some variation in appetite and weight loss linked to their menstrual cycle. Understanding these patterns allows for better planning and coping strategies.
Tracking cycles, adjusting diet and exercise, and seeking professional advice when needed can help maintain steady progress. Weight loss is a journey with ups and downs, and recognising the role of hormones can empower women to stay on track.

Disclaimer: This article provides general information and is not a substitute for professional medical advice. Consult a healthcare provider for personalised guidance.



